Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Oncotype DX Breast Cancer Assay

Known as: Oncotype DX 
A diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
PURPOSE This focused update addresses the use of Oncotype DX in guiding decisions on the use of adjuvant systemic therapy… Expand
  • table 2
  • table 3
Is this relevant?
Review
2017
Review
2017
Implementation of the Oncotype DX assay has led to a change in the manner in which chemotherapy is utilized in patients with… Expand
  • table 1
  • figure 1
Is this relevant?
2017
2017
PurposeOncotype DX (ODX) recurrence score (RS) breast cancer (BC) assay is costly, and performed in only ~1/3 of estrogen… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2015
Highly Cited
2015
Oncotype DX (Genomic Health, Redwood City, CA, USA, current list price $4,350.00) is a multigene quantitative reverse… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND We critically evaluated the available evidence on genomic tests in breast cancer to define their prognostic ability… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2011
Highly Cited
2011
PURPOSE The Oncotype DX assay predicts likelihood of distant recurrence and improves patient selection for adjuvant chemotherapy… Expand
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Oncotype DXTM is an RT-PCR-based assay used to predict chemotherapy benefit in patients with estrogen receptor (ER) positive… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2010
Highly Cited
2010
The use of clinicopathologic features in decision-making in early stage estrogen receptor (ER)-positive breast cancer (BC) may… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Novel genetic profiling tests of breast cancer tissue have been shown to be prognostic for overall survival and predictive of… Expand
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2006
Highly Cited
2006
  • V. Kaklamani
  • Expert review of molecular diagnostics
  • 2006
  • Corpus ID: 12514043
We now recognize that not all breast cancers are the same. Different characteristics in gene expression profiles result in… Expand
Is this relevant?